
Sign up to save your podcasts
Or


The US central bank has left interest rates unchanged this month but says they will be cut three times before the end of the year. We look into the details.
The world's most expensive drug will soon be available in the US at a price of $4.25m. We hear about the rare disease it treats and the high cost of developing medicine to battle it.
Sam Fenwick discusses these and more business stories with two guests on opposite sides of the world: Kristina Hooper, Chief Global Market Strategist at New York-based Invesco, and Yoko Ishikura, Professor Emeritus at Hitotsubashi University.
(Picture: US Federal Reserve Board Chairman Jerome Powell. Picture credit: SHAWN THEW/EPA-EFE/REX/Shutterstock.)
By BBC News4.3
4848 ratings
The US central bank has left interest rates unchanged this month but says they will be cut three times before the end of the year. We look into the details.
The world's most expensive drug will soon be available in the US at a price of $4.25m. We hear about the rare disease it treats and the high cost of developing medicine to battle it.
Sam Fenwick discusses these and more business stories with two guests on opposite sides of the world: Kristina Hooper, Chief Global Market Strategist at New York-based Invesco, and Yoko Ishikura, Professor Emeritus at Hitotsubashi University.
(Picture: US Federal Reserve Board Chairman Jerome Powell. Picture credit: SHAWN THEW/EPA-EFE/REX/Shutterstock.)

7,913 Listeners

4,225 Listeners

523 Listeners

1,067 Listeners

50 Listeners

296 Listeners

1,808 Listeners

357 Listeners

201 Listeners

96 Listeners

684 Listeners

232 Listeners

1,089 Listeners

0 Listeners

1 Listeners

0 Listeners

6 Listeners

13 Listeners

4 Listeners

1 Listeners

36 Listeners

0 Listeners

194 Listeners

146 Listeners

3 Listeners